0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Strengths available for Osimertinib :

Osimertinib 40mg
Osimertinib 80mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about GlobalPharmacyMeds.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Osimertinib:

  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Barbados
  • Belarus
  • Belgium
  • Bermuda
  • Bosnia and Herzegovina
  • Bulgaria
  • Chile
  • Dominican Republic
  • Ecuador
  • Estonia
  • Georgia
  • Greece
  • Grenada
  • Guatemala
  • Honduras
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Jordan
  • Latvia
  • Moldova, Republic of
  • Netherlands Antilles
  • Peru
  • Romania
  • Saint Lucia
  • Saudi Arabia
  • Serbia
  • South Africa
  • Sweden
  • Tonga
  • Turkey
  • Ukraine
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
View All Countries

Latest news releases on Osimertinib:

TAGRISSO® (osimertinib) | Official Global Site

Discover the new first-line TAGRISSO efficacy (PFS) data in NSCLC and access information about safety, MOA, dosing, AURA3 and other resources

Osimertinib - Chemocare - Side Effects - Drug Info ...

Osimertinib (Tagrisso) EGFR kinase inhibitor targeted therapy side effects, how it's given, how it works, precautions and self care tips for treatment of non-small ...

Osimertinib or Platinum–Pemetrexed in EGFR T790M ...

Osimertinib is an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that is selective for both EGFR-TKI sensitizing and T790M resistance mutations ...

Nutzenbewertungsverfahren zum Wirkstoff Osimertinib (neues ...

Anwendungsgebiet gemäß Fachinformation für Osimertinib (Tagrisso®) Tagrisso ist als Monotherapie angezeigt zur: Erstlinientherapie von erwachsenen Patienten mit ...

Nutzenbewertungsverfahren zum Wirkstoff Osimertinib ...

Anwendungsgebiet gemäß Fachinformation für Osimertinib (Tagrisso®) Tagrisso ist angezeigt zur Behandlung von erwachsenen Patienten mit lokal fortgeschrittenem ...

DRUG NAME: Osimertinib - BC Cancer

Osimertinib DRUG NAME: Osimertinib SYNONYM(S): AZD92911, osimertinib mesylate 2. COMMON TRADE NAME(S): TAGRISSO® CLASSIFICATION: molecular targeted therapy

Osimertinib (Tagrisso) bei fortgeschrittenem Lungenkrebs ...

Osimertinib (Handelsname Tagrisso) ist seit Juni 2018 zur Erstbehandlung von fortgeschrittenem Lungenkrebs mit aktivierenden Mutationen des epidermalen ...

TAGRISSO (osimertinib) tablets - Food and Drug Administration

Company: AstraZeneca Pharmaceuticals, LP Application No.: 208065 Approval Date: 11/13/2015. Persons with disabilities having problems accessing the PDF files below ...

Osimertinib versus Standard of Care EGFR TKI as First-Line ...

Introduction. Here we report efficacy and safety data of an Asian subset of the phase III FLAURA trial (NCT02296125), which compares osimertinib with standard of care ...

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC ...

This study (the SAVANNAH study) will investigate the efficacy of osimertinib in combination with savolitinib in patients with EGFRm+ and MET+, locally advanced or ...

Customer Service
1-866-799-3435 (Use ref# 10786) | Contact Form
Copyright © 2019 GlobalPharmacyMeds.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK